A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures

被引:16
作者
Xie, Lihua [1 ]
Hu, Xuantao [2 ]
Li, Wenzhao [2 ]
Ouyang, Zhengxiao [2 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China
关键词
ESRD; Fragility fracture; Risk factors; Prognosis; SERUM ALKALINE-PHOSPHATASE; HIP FRACTURE; ECONOMIC BURDEN; OSTEOPOROSIS; MORTALITY; RISK; CALCIFICATION; PREVALENCE;
D O I
10.1186/s12882-020-02224-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients.MethodsIn this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis.ResultsThe FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (P < .001, RR: 4.877, 95% CI: 2.367-10.013).ConclusionsEssential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Hemodialysis access type is associated with blood pressure variability and echocardiographic changes in end-stage renal disease patients [J].
Liao, Ruoxi ;
Wang, Liya ;
Li, Jiameng ;
Lin, Liping ;
Sun, Si ;
Xiong, Yunqin ;
Li, Yupei ;
Han, Mei ;
Su, Baihai .
JOURNAL OF NEPHROLOGY, 2019, 32 (04) :627-634
[42]   Aiming for the optimal bicarbonate prescription for maintenance hemodialysis therapy in end-stage renal disease [J].
Bozikas, Andreas ;
Kiriakoutzik, Iliana ;
Petrou, Ioannis ;
Touroutzis, Theodoros ;
Kitoukidi, Eleni ;
Pisanidou, Pinelopi ;
Vakiani, Styliani ;
Georgilas, Nikolaos ;
Martika, Antigoni ;
Pangidis, Panagiotis ;
Spaia, Sofia .
HEMODIALYSIS INTERNATIONAL, 2019, 23 (02) :173-180
[43]   The instant impact of a single hemodialysis session on brain morphological measurements in patients with end-stage renal disease [J].
Peng, Cong ;
Ran, Qian ;
Liu, Cheng Xuan ;
Zhang, Ling ;
Yang, Hua .
FRONTIERS IN HUMAN NEUROSCIENCE, 2022, 16
[44]   Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients [J].
Xue, Cheng ;
Sun, Bo ;
Ye, Xiaofei ;
Zhou, Chenchen ;
Yang, Bo ;
Zhang, Liming ;
Yu, Shengqiang .
BLOOD PURIFICATION, 2020, 49 (1-2) :85-92
[45]   Prevalence and Risk Factors of Osteoporosis in Saudi End-stage Renal Disease Patients on Hemodialysis [J].
Mahzari, Moeber M. ;
Alibrahim, Ahmed R. ;
Alghamdi, Nawaf A. ;
Alsadhan, Muatassem A. ;
Almoamary, Saad M. ;
Masuadi, Emad M. ;
Al Shahrani, Awad S. .
SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2022, 10 (03) :259-+
[46]   Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation [J].
Jagdale, Abhijit ;
Cooper, David K. C. ;
Iwase, Hayato ;
Gaston, Robert S. .
XENOTRANSPLANTATION, 2019, 26 (02)
[47]   Carotid artery calcification and atherosclerosis at the initiation of hemodialysis in patients with end-stage renal disease [J].
Sumida, Y. ;
Nakayama, M. ;
Nagata, M. ;
Nakashita, S. ;
Suehiro, T. ;
Kaizu, Y. ;
Ikeda, H. ;
Izumaru, K. .
CLINICAL NEPHROLOGY, 2010, 73 (05) :360-369
[48]   Impact of End-Stage Renal Disease and Hemodialysis in Physical and Psychosocial Status of Elderly Patients [J].
Hefnawy, Gehan Refat Mohamed .
BIOSCIENCE RESEARCH, 2020, 17 (01) :1-12
[49]   Renal cell carcinoma in end-stage renal disease: A retrospective study in patients from Hungary [J].
Semjen, David ;
Denes, Borbala ;
Somoracz, Aron ;
Fintha, Attila ;
Forika, Gertrud ;
Jenei, Alex ;
Dobi, Dejan ;
Micsik, Tamas ;
Eizler, Kornelia ;
Giba, Nandor ;
Santa, Fanni ;
Sejben, Anita ;
Ivanyi, Bela ;
Kuthi, Levente .
PATHOBIOLOGY, 2023, 90 (05) :322-332
[50]   The Effect of Kidney Transplantation on Pulmonary Hypertension in End-stage Kidney Disease Patients on Hemodialysis [J].
Jane, Christine Mary ;
Kumar, K. Vinod ;
Kumar, R. Anil ;
Unni, V. Narayanan ;
Prasannan, Bipi K. ;
Pullockara, Jojo K. ;
Dev, U. R. S. Vishnu .
INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (04) :385-392